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Decorin GAG Synthesis and TGF- Signaling Mediate
Ox-LDL–Induced Mineralization of Human Vascular
Smooth Muscle Cells
Jianyun Yan, Sally E. Stringer, Andrew Hamilton, Valentine Charlton-Menys, Christian Go¨tting,
Benjamin Mu¨ller, Daniel Aeschlimann, M. Yvonne Alexander
Objective—Decorin and oxidized low-density lipoprotein (Ox-LDL) independently induce osteogenic differentiation of
vascular smooth muscle cells (VSMCs). We aimed to determine whether decorin glycosaminoglycan (GAG) chain
synthesis contributes to Ox-LDL–induced differentiation and calcification of human VSMCs in vitro.
Methods and Results—Human VSMCs treated with Ox-LDL to induce oxidative stress showed increased alkaline
phosphatase (ALP) activity, accelerated mineralization, and a difference in both decorin GAG chain biosynthesis and
CS/DS structure compared with untreated controls. Ox-LDL increased mRNA abundance of both xylosyltransferase
(XT)-I, the key enzyme responsible for GAG chain biosynthesis and Msx2, a marker of osteogenic differentiation.
Furthermore, downregulation of XT-I expression using small interfering RNA blocked Ox-LDL–induced VSMC
mineralization. Adenoviral-mediated overexpression of decorin, but not a mutated unglycanated form, accelerated
mineralization of VSMCs, suggesting GAG chain addition on decorin is crucial for the process of differentiation. The
decorin-induced VSMC osteogenic differentiation involved activation of the transforming growth factor (TGF)-
pathway, because it was attenuated by blocking of TGF- receptor signaling and because decorin overexpression
potentiated phosphorylation of the downstream signaling molecule smad2.
Conclusion—These studies provide direct evidence that oxidative stress–mediated decorin GAG chain synthesis triggers
TGF- signaling and mineralization of VSMCs in vitro. (Arterioscler Thromb Vasc Biol. 2011;31:608-615.)
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Vascular calcification is a life-threatening complication ofcardiovascular disease1,2 and is an independent risk
factor for high morbidity and mortality.3 Oxidative stress is
among the important factors contributing to the progression
of vascular calcification4 and is known to induce cytoskeletal
disorganization, as well as downregulate smooth muscle cell
gene expression5 and activate genes that lead to increased
deposition of extracellular matrix (ECM) proteins,6 notably,
the profibrotic cytokine transforming growth factor (TGF)-.
However, the molecular mechanism by which oxidative stress
accelerates mineralization is still not fully understood.
Many studies have identified a similarity between miner-
alization of bones and teeth with the pathophysiological ECM
calcification that occurs in blood vessels (reviewed by Demer
and Tintut7). Skeletal ECM mineralizes under physiological
conditions and is an active process involving production of
specific gene products. Similarly, under pathological condi-
tions, ECM soft tissue mineralization is also thought to be an
active process, occurring in response to loss of osteogenic
inhibitory molecules, rather than passive mineral precipita-
tion. Knockout mouse studies have shown that many inhibi-
tory factors are secreted ECM proteins, such as osteopontin,
matrix Gla protein, and osteoprotegerin. Thus, the ECM can
act as a reservoir of bioactive structural proteins that influ-
ence cell behavior in response to tissue injury.
One important component of the matrix is the small
leucine-rich proteoglycan (SLRP), decorin, consisting of a
core protein and single glycosaminoglycan (GAG) chain
(chondroitin or dermatan sulfate [CS/DS]). It is expressed in
many connective tissues such as developing and adult bone,
blood vessels, and skin. Studies have shown that the decorin
core protein can bind to TGF- isoforms, thus regulating
TGF-/ECM interactions.8 Both TGF- and decorin have
been implicated in promoting vascular calcification,9,10 al-
though 1 study demonstrated decorin-induced inhibition of
matrix mineralization in vitro.11 Differences in the GAG
chain composition of decorin could account for the discrep-
ancy, such as occurs in different tissues,12 in the development
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of atherosclerosis and calcification progression13,14 and vas-
cular remodeling,15 and similar to the pro- and antiathero-
genic properties of another proteoglycan perlecan.16
Oxidized low-density lipoprotein (Ox-LDL) has been
shown to modulate decorin GAG chain synthesis.17 The GAG
chain hinders interaction between decorin core protein and
TGF-,18 and hence it may be that decorin CS/DS chain
synthesis regulates the sequestration/bioavailability of TGF-
in the vessel wall. A key question arising is whether the
enzymes xylosyltransferase (XT)-I and XT-II19 involved in
the initial and rate-limiting step in CS/DS chain synthesis, are
modulated in oxidative stress–induced vascular calcification.
Therefore, we aimed to determine whether GAG chain
synthesis on decorin plays an important role in Ox-LDL–
induced osteogenic differentiation of VSMCs and to establish
the downstream signaling pathway involved.
Methods
An expanded Methods section is available in the online Data
Supplement at http://atvb.ahajournals.org.
Cell Culture
Human vascular smooth muscle cells (VSMCs) from tibial arteries
from consenting adults were isolated as described in the supplemen-
tal Methods section.
LDL Preparation and Oxidation
LDL (density 1.019 to 1.063 g/mL) was isolated from healthy human
plasma by sequential ultracentrifugation and oxidized as described
(supplemental Methods).
Recombinant Adenoviral Infection of Vascular
Smooth Muscle Cells
Cells were seeded in either 25 cm2 cell culture flasks or 6-well plates
at 4104 cells/cm2 and grown in DMEM supplemented with 10%
FBS overnight to reach 80% confluence. Adenovirus encoding
decorin (Ad/DCN) and adenovirus encoding GAG-free decorin
(Ad/S34A)20 were used to infect VSMCs at a multiplicity of
infection (MOI)100 as described (supplemental Methods).
Measurement of Calcification
Alizarin red staining and quantification and ALP analysis are
available online (supplemental Methods).
Xylosyltransferase Small Interfering
RNA Transfection
A total of 1106 cells were transfected with 30 L of 2.5 mol/L
scrambled negative control, XT-I, XT-I small interfering (si)RNA
or 2 g of pmaxGFP, as described (supplemental Methods) and
harvested at the indicated time points.
Quantitative Real-Time PCR
Quantitative PCR was performed using 7900 HT Fast Real-Time
PCR system and SYBR green detector (Applied Biosystems) using
primers for decorin, XT-I, XT-II, Msx2. Transcripts were normalized
to -actin. Primers used for quantitative RT-PCR were as follows
-actin forward, CCAGCTCACCATGGATGATG; -actin reverse,
GAGCCGTTGTCGACGACG; decorin forward, TCAGCTTT-
GAGGGCTCCTGT; decorin reverse, ACCAGGGAACCTTTTA-
ATCCG; XT-I forward, CCTGCCTGGAAAGTGATAGCAC; XT-I
reverse, GAACACTACCCATCTGCTGGG; XT-II forward, AT-
CACGAGCAGCACTTCTTTTACAT; XT-II reverse, GG-
TAGTCGGAACGCTTGTCC; Msx2 forward, TGGATGCAG-
GAACCCGG; Msx2 reverse, AGGGCTCATATGTCTTGGCG.
Western Blot Analysis
Total protein was extracted from VSMC cultures and quantified
using a BCA protein assay kit. Western blot analysis was performed
as described in the online supplement. To detect decorin core protein,
chondroitinase ABC (0.2 U/mL overnight at 37°C) was used to
remove the GAG chain from decorin.
GAG Extraction and Analysis
CS/DS was extracted as described for gags in Pan et al21 and then
chondroitinase ABC–digested, and the resultant disaccharides derivat-
ized with the fluorophore 2-aminoacridone (AMAC, Sigma).22 Disac-
charides were separated by high-performance liquid chromatography on
a Kinetex 2.6 m C18 column (Phenomenex, UK) in a 10% to 30%
gradient of methanol in 0.1 mol/L ammonium acetate over 20 minutes
at 1 mL/min and quantified according to known standards.
Quantification of Active and Total TGF-1
TGF-1 levels in 100 L of conditioned media were determined using
the TGF-1 EMax Immunoassay kit (Promega), which was performed
according to the instructions of the manufacturer. To determine total
TGF-1 levels, the conditioned media were acidified with 1 L of 1N
HCl and neutralized after 15 minutes at 22°C with 1N NaOH.
Results
Ox-LDL Accelerates Calcification of Vascular
Smooth Muscle Cells
We investigated Ox-LDL effects on mineralization, and
alizarin red staining showed that Ox-LDL accelerated calci-
fication of human VSMCs in a dose-dependant manner, an
effect not detected when using native LDL (supplemental
Figure I). For all future experiments, 30 g/mL Ox-LDL was
used to treat the cells as our model of induced-oxidative
stress. A time-course experiment showed that mineralization
was detected as early as day 7 in the presence of Ox-LDL,
with increased mineralization at day 14 (Figure 1A). Quan-
tification of alizarin red staining showed a 1.9-fold increase in
alizarin red retention in VSMCs after Ox-LDL treatment for
7 days and 3.1-fold increase at day 14 compared with
untreated controls (Figure 1B). Culturing VSMCs for 7 and 14
days in the presence of Ox-LDL also increased ALP activity by
18- and 2.3-fold respectively, compared with untreated controls
(Figure 1C). In addition, we detected a3-fold increase in Msx2
mRNA expression after Ox-LDL treatment at both days 7 and
14 (Figure 1D). Of note, no change in Cbfa1 mRNA abundance
was apparent during this time course and under these treatment
conditions (data not shown).
GAG Synthesis but Not Decorin Gene Expression
in VSMCs Is Altered by Ox-LDL Treatment
Western blot analysis of VSMC protein lysates detected less
decorin core protein in Ox-LDL treated cells compared with
untreated control cells. However, removing GAG chains with
chondroitinase ABC digestion allowed similar levels of core
protein in Ox-LDL–treated cells to be detected compared with
untreated controls (Figure 2A). Decorin gene expression was
also analyzed in lysates from cells grown in the presence and
absence of Ox-LDL using quantitative PCR. We detected no
change in decorin mRNA expression between the two treatment
groups (Figure 2B).
Next, we isolated GAGs from cells grown in the presence
and absence of Ox-LDL (supplemental Figure II). Changes in
the amount of CS/DS were insignificant, with 22.4 ng/g
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protein in untreated compared with 19.1 ng/g protein in
Ox-LDL–treated cells. This is consistent with there being no
major changes in chain length. However, we detected a
significant increase in CS/DS disaccharides containing 4-O-
and/or 6-O-sulfation (Figure 2C).
Ox-LDL Enhances XT-I mRNA Expression in VSMCs
Quantitative PCR analysis showed that osteogenic differentia-
tion of VSMCs was associated with increased XT-I mRNA
(Figure 2D) but not XT-II mRNA (Figure 2E) expression and that
Ox-LDL further increased XT-I mRNA expression by 2.4-fold at
day 4, by 2.7-fold at day 7, and by 3.6-fold at day 14, respectively.
Decorin GAG Chain Is Essential for
Ox-LDL–Induced Mineralization of VSMCs
Our data demonstrate that overexpression of wild-type decorin
(supplemental Figure III) overtly promotes mineralization in
human VSMCs (Figure 3A). However, VSMCs infected with
Figure 1. Effect of Ox-LDL on VSMC
mineralization. A and B, Alizarin red
staining (A) and quantification (B). C,
ALP activity, expressed as nmol/mL
-nitrophenol converted per microgram
of cellular protein per minute. D, Msx2
mRNA expression measured after
Ox-LDL treatment. *P0.001.
Bar200 m.
Figure 2. Ox-LDL effects on decorin
expression, chondroitin/dermatan sulfate
structure, and XT-I mRNA expression in
VSMCs. A, Cells were grown with or
without 30 g/mL Ox-LDL over 14 days
(n4). Western blot analysis established
decorin core protein expression in
VSMCs with or without chondroitinase
ABC (ABC) to remove the GAG chain
from decorin. -Tubulin was a loading
control. B, Quantitative RT- PCR analy-
sis of decorin mRNA expression in
VSMCs expressed as a relative fold
change compared with -actin mRNA.
High-performance liquid chromatography
showed the disaccharide composition of
CS/DS from VSMCs. C, Levels of 2-O-
sulfated (2S), 4-O-sulfated (4S), 6-O-
sulfated, and total sulfated (total S) dis-
accharides. *P0.05; **P0.005. D and
E, Quantitative PCR was used to analyze
XT-I mRNA (D) and XT-II mRNA (E) from
VSMCs (n4) and are presented as rela-
tive fold increase over actin mRNA.
*P0.001.
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Ad/S34A demonstrated 65% and 84% less mineralization com-
pared with Ad/DCN-infected cells at days 7 and 14 respectively
(Figure 3B). Similarly, ALP activity was increased by 8.3- and
2.8-fold in decorin-infected cells at day 7 and day 14 respec-
tively, whereas Ad/S34A-infected VSMCs failed to show ele-
vated levels of ALP activity compared with decorin-infected or
control Ad/LacZ-infected cells (Figure 3C). Next, to determine
combined effects of Ox-LDL and decorin overexpression on
ALP activity and subsequent VSMC mineralization, VSMCs
were infected with Ad/DCN or Ad/S34A under control (osteo-
genic) and oxidative stress conditions for 7 days. Cells infected
with Ad/DCN together with Ox-LDL treatment, showed a
10-fold increased mineralization compared with control Ad/
LacZ-infected cells, under oxidative stress conditions by day 7 in
culture, and a 7.5-fold increased mineralization compared with
the same cells grown under control osteogenic conditions (Fig-
ure 4A and 4B). In contrast, GAG-free decorin was incapable of
enhancing mineralization either in the presence or absence of
Ox-LDL (Figure 4A and 4B). In cells infected with Ad/LacZ
and Ad/S34A, Ox-LDL enhanced ALP activity in line with
expectations (Figure 1C).
Of note, ALP activity was significantly increased in cells
infected with Ad/DCN under both osteogenic and oxidative
stress conditions, compared with Ad/LacZ infected-cells,
whereas no similar increase in ALP activity was detected in
GAG-free decorin overproducing cells (Figure 4C). These
data suggest a key role of the GAG chain of decorin in
modulating osteogenic differentiation of VSMCs.
To further verify that GAG chain synthesis plays an important
role in Ox-LDL–induced mineralization of VSMCs, XT-I and
XT-II siRNAs were then used to transfect VSMCs in the
presence of Ox-LDL. Quantitative PCR confirmed significant
Figure 3. Effect of decorin or mutant decorin overexpression on
mineralization of VSMCs. A and B, Alizarin red staining and min-
eral deposition were quantified in Ad/lacZ-, Ad/DCN-, or
Ad/S34A-infected cells grown in osteogenic medium over a
14-day time course (n3). C, ALP activity was assessed in a
parallel experiment and expressed as nmol/mL -nitrophenol
converted per microgram of cellular protein per minute.
*P0.001; **P0.01. Bar200 m.
Figure 4. Decorin-induced mineralization of VSMCs is enhanced
by Ox-LDL treatment and requires decorin GAG chain. Cells
infected with Ad/lacZ, Ad/DCN, or Ad/S34A were grown in
osteogenic medium (control) or osteogenic medium containing
30 g/mL Ox-LDL for 7 days (n3). A, Cells were stained with
alizarin red. Bar200 m. B, Mineral deposition was quantified.
C, ALP activity was assessed in a parallel experiment.
*P0.001.
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downregulation of XT-I and XT-II mRNA expression in respec-
tive siRNA-transfected cells compared with other groups (Figure
5A and 5B). Mineralization, detected by alizarin red staining of
VSMCs, was reduced by 65% in XT-I siRNA-transfected cells
at day 10, as compared with controls but unaffected when XT-II
expression was downregulated (Figure 5C and 5D). Further-
more, the osteogenic transcription factor, Msx2 mRNA expres-
sion in XT-I, but not XT-II siRNA-transfected cells was down-
regulated 3-fold compared with control groups (Figure 5E).
Taken together, these data suggest that the function of decorin as
an inducer of VSMC mineralization is dependent on GAG chain
addition by XT-I. In turn, altered posttranslational modification
could affect its ability to bind to and sequester TGF-, although
the GAG chain does not seem to be involved directly in
TGF-/decorin interaction.23
TGF- Signaling Is Required for
Ox-LDL–Induced Mineralization of VSMCs
We investigated whether TGF- signaling is required for
Ox-LDL–induced mineralization of VSMCs. SB431542 (an
inhibitor of TGF- type I receptor) was used to treat VSMCs
in the presence of Ox-LDL. We found that chemical inhibi-
tion of TGF- signaling attenuated the Ox-LDL–induced
mineralization of VSMCs (supplemental Figure IVA and
IVB). Furthermore, ELISA showed elevated production of
active TGF-1 in Ox-LDL–treated cells versus controls
(Figure 6A) with no change in absolute levels of total TGF-
protein after acid activation (Figure 6B). Western blot anal-
ysis showed that expression of the downstream target of
TGF-, namely smad2, was unchanged at all time points and
in all treatment regimes. However, Ox-LDL treatment of cells
stimulated phosphorylation of smad2, an effect which was
inhibited by SB431542 (Figure 6C).
Decorin-Induced Mineralization Is Dependent on
Activation of TGF- Signaling
To confirm links among Ox-LDL, decorin, TGF-, and miner-
alization, SB431542 was used to treat Ad/DCN-infected
VSMCs. Alizarin red staining shows that decorin accelerates
mineralization by day 14 compared with control cells, and
decorin-induced mineralization of VSMCs is attenuated by
treatment with SB431542 (supplemental Figure VA and VB).
To establish the essential requirement of GAG chain synthesis
on decorin for the activation of the TGF- pathway, cells were
transduced with either Ad/DCN or Ad/S34A. TGF-1 activation
was substantially increased in Ad/DCN-infected cells compared
with Ad/LacZ-infected cells (Figure 6D). Active TGF-1 pro-
duction was significantly reduced in Ad/S34A-infected com-
pared with Ad/DCN infected cells. However, it was significantly
elevated compared with Ad/LacZ controls (Figure 6D). Phos-
phorylation of smad2 was detected in lysates from cells har-
vested at each time point after overexpression of decorin (Figure
6E), whereas no phosphorylation of smad2 was detected in the
presence of SB431542 (Figure 6E). In line with reduced levels
of active TGF-, less phosphorylated smad2 was detected in
Ad/S34A-infected cells compared with Ad/DCN-infected cells
(Figure 6F).
Further downstream mechanisms were investigated using
quantitative PCR analysis to confirm a link between decorin
and osteogenic differentiation. Decorin overexpression was
shown to increase Msx2 mRNA expression by 4- and
7-fold at days 7 and 14, respectively. However, addition of
Figure 5. Effect of XT-I and XT-II siRNA
on mineralization of VSMCs. Cells were
transfected with XT-I or XT-II siRNA at
90% confluence, and 24 hours later,
growth medium was replaced by osteo-
genic medium containing 30 g/mL
Ox-LDL (n3). A and B, Total RNA was
isolated from cells transfected with XT-I
or XT-II siRNA at day 2. Quantitative
PCR analysis shows successful down-
regulation of XT-I and XT-II mRNA
expression in XT-I or XT-II siRNA-
transfected cells. C, Cells were stained
with alizarin red. Bar200 m. D, Min-
eral deposition was quantified at day 10.
E, Quantitative PCR analysis of Msx2
mRNA expression in cells transfected
with XT-I or XT-II siRNA. *P0.001.
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the TGF- inhibitor SB431542 caused a 50% reduction of
Msx2 mRNA expression at day 14 compared with cells
overexpressing decorin alone (Figure 6G).
Discussion
In the present study, we demonstrate that decorin GAG chain
plays a crucial role as an inducer of VSMC biomineralization
and that activation of TGF- signaling and upregulation of
Msx2 underpins Ox-LDL–induced mineralization of VSMCs.
We show that Ox-LDL increases ALP activity and accelerates
mineralization of VSMCs. These findings are consistent with a
previous study in which minimally oxidized-LDL increases
ALP activity and mineralization of calcifying vascular cells.24
Identifying the molecular mechanisms by which vascular calci-
fication occurs has important clinical implications, as therapies
can then be tailored to target those patients at most risk.
Decorin consists of a core protein and single GAG chain of
CS or DS and both overexpression of decorin,10 and variable
modification of decorin GAG chains in different tissues has been
implicated in regulation of mineralization.14 We now demon-
strate that GAG chain synthesis is essential for the procalcifica-
tion role of decorin under conditions of oxidative stress. GAGs
are negatively charged polysaccharides that, when covalently
bound to proteins, contribute to the structural integrity and
regulatory functions of the ECM. There is a growing recognition
of the importance of not only heparin and heparan sulfates but
also for the CS/DS chains. We find that less decorin core protein
was detected in Ox-LDL–treated cells compared with untreated
controls. However, removing GAG chains by ABC chondroiti-
nase digestion yields similar levels of core protein after Ox-
LDL–treatment of cells compared with untreated controls. This
finding suggests that Ox-LDL has no effect on decorin gene
expression per se, but it contributes to the conversion of decorin
core protein to its glycanated form by adding GAG chains. XT-I
and XT-II are the enzymes responsible for the initiation of GAG
chain synthesis, and XT-I levels were shown to be increased
during osteogenic differentiation of mesenchymal stem cells.25
We now show that Ox-LDL increases XT-I but not XT-II
mRNA expression, confirming that Ox-LDL alters GAG chain
synthesis of vascular proteoglycans, as reported previously.17
Despite XT-1 upregulation and enhanced GAG attachment to
decorin, there was no overall increase in CS/DS levels on all
proteoglycans present in VSMCs during oxidative stress.
To determine whether GAG addition specifically on decorin
plays a crucial role in bio-mineralization, we compared the
effects of Ad/DCN or decorin core protein (Ad/S34A) on
mineralization. Ad/DCN induces VSMC mineralization by day
7, with strong mineral staining by day 14, whereas very little, if
any, mineralization was detected in cells infected with the
unglycanated S34A DCN mutant or in control cells, which take
the normal 21 days to mineralize under osteogenic conditions
(data not shown). Moreover, Ad/DCN-accelerated VSMC min-
eralization is further enhanced by concomitant treatment with
Ox-LDL, detected as early as day 7 in culture, whereas mutant
Figure 6. TGF- signaling is activated
during the process of decorin- or Ox-
LDL–induced mineralization of VSMCs.
A, B, and D, Active (A) and total (B)
TGF-1 levels in conditioned media were
measured using EMax immunoassay
after treatment of cells with/without 30
g/mL Ox-LDL and with/without
20 mol/L TGF- receptor kinase inhibi-
tor SB431542 (SB) and infected with
Ad/lacZ, Ad/DCN, and AdS34A with/
without 10mol/L SB431542 (D). C, E,
and F, Western blot analysis of cell
lysates showing smad2 and p-smad2
expression in VSMCs under the treat-
ment regimes indicated. G, Quantitative
PCR analysis of Msx2 mRNA expression
in cells treated with Ad/lacZ, Ad/DCN,
and/or SB. *P0.001, **P0.01,
***P0.05.
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decorin, free of GAG chain, is not capable of enhancing VSMC
mineralization either in the presence or absence of Ox-LDL.
Ad/DCN-induced ALP activity was also further enhanced by
Ox-LDL treatment. The finding that XT-I siRNA blocks oxida-
tive stress–induced VSMC mineralization supports our hypoth-
esis that addition of GAG chain on decorin plays a significant
role in Ox-LDL–induced mineralization of VSMCs and could
affect its ability to bind to and sequester TGF-. However, these
data do not exclude a role of other CS/DS proteoglycans in
Ox-LDL–induced SMC mineralization. Consistent with our
findings that GAG chain synthesis on decorin is critical for
Ox-LDL–induced SMC mineralization, recent studies have
shown that oversulfated chondroitin sulfate promotes osteoblast
differentiation and mineralization14 and that increased levels of
XT-I have been linked with osteogenic differentiation of mes-
enchymal stem cells.25 Our results support studies by Muller et
al,25 who found that XT-I, not XT-II, correlated with osteogenic
differentiation of mesenchymal stem cells and that XT-II was
not regulated by TGF-.25 The increased 4-sulfated CS/DS
detected under oxidative stress conditions may also promote
mineralization as reported previously.14 The observed increase
in 4-sulfated and 4,6-sulfated CS is also consistent with the
reported role of TGF- in regulating chondroitin 4-O-
sulfotransferase activity.26
It has been shown that decorin regulates TGF- bioactiv-
ity27 and TGF- induces VSMC calcification.9 However, the
role of TGF- in Ox-LDL–induced mineralization and the
link between TGF- and decorin in this pathological process
is unclear. To determine whether decorin regulates TGF-
bioactivity, we used Ad/DCN to overexpress decorin in
VSMCs and investigated the effect on phosphorylation of
smad2, and we assessed the effects of the TGF- inhibitor
SB431542. We show that (1) overexpression of decorin
significantly enhances TGF- activation, without changes in
total TGF- protein levels, and results in subsequent smad2
phosphorylation; (2) decorin-induced TGF- signaling accel-
erates osteogenic differentiation of VSMCs; and (3)
SB431542 treatment inhibits both smad2 phosphorylation
and decorin-induced mineralization of VSMCs.
Binding of decorin to TGF- has been investigated in some
detail but how decorin affects the function of TGF- in a
certain biological setting is less clear. Direct effects on
signaling and sequestration of TGF- have both been pro-
posed.28,29 Although the finding that intact GAG-carrying
decorin promotes TGF- signaling and osteogenic differen-
tiation could be consistent with the fact that GAG chain
addition interferes with TGF- binding to decorin core
protein18 and hence inhibits sequestration of TGF-, several
of our findings contradict such a model. Firstly, overexpres-
sion of decorin core protein (Ad/S34A) should have a
dominant-negative effect on Ox-LDL–mediated differentia-
tion/mineralization but has no effect (Figure 4C). Secondly,
activation of TGF- is slightly elevated in Ad/S34A-infected
cells compared with the Ad/LacZ controls in Figure 6D, with
the smad 2 phosphorylation data shown in Figure 6F being
consistent with this finding. These data suggest a partial
activation of the pathway with GAG-less decorin at later time
points. Both findings would be more consistent with a model
whereby intact decorin promotes active TGF- production,
with the GAG chain facilitating an interaction necessary in
this process and hence reducing the effective concentration
needed in comparison to decorin core protein alone. TGF-1
and -2 have been shown to bind to highly sulfated heparan
sulfate proteoglycans,30 and recent research suggests CS/DS
can replace heparan sulfate in certain growth factor interac-
tions.31 Alternatively, it could be that binding of decorin to
additional factors, rather than direct binding to TGF-,
activates TGF-. Furthermore, the fact that inhibition of
TGF- receptor signaling blocks active TGF- accumulation
(Figure 6A and 6D) suggests that TGF- signaling is needed
to induce the observed substantial upregulation of TGF-
bioactivity. This autocrine activation loop is in agreement
with Mori et al32 who also demonstrate TGF- autoinduction
in a human dermal fibroblast transdifferentiation model. The
present observation that decorin enhances TGF- bioactivity
in VSMCs without change in total TGF- protein supports a
mechanism of regulation involving posttranslational control
of TGF- activation or active TGF- availability or enhanced
receptor signaling complex formation. One possible mecha-
nism is that the increase in 4-sulfation seen after Ox-LDL
treatment is TGF-–mediated,8 which in turn could be
important for TGF- activation. If XT-I is regulated by
TGF- and this in turn results in glycanation of decorin and
thereby enhanced TGF- activation, then this could explain
the autoactivation loop. In summary, we have shown that
Ox-LDL increases XT-I mRNA expression, enabling decorin
GAG synthesis and, in turn, elevating TGF- bioavailability
to activate downstream signaling pathways.
Msx2 is a homeodomain transcription factor that has been
shown to control osteoblast differentiation and mineralization
in the developing skull.33 Msx2 expression is regulated by
TGF- family members including bone morphogenetic pro-
tein (BMP)-2 and TGF-.34 Moreover, others have reported
that Msx2 promotes vascular calcification.35 Although some
have reported the expression of both Cbfa1 and Msx2 in
calcified vessels,36 others have distinguished endochondral from
intramembranous ossification through BMP-2–Cbfa1 and BMP-
2–Msx2 signal pathways, respectively.37 In this study, we show
that Ox-LDL activates TGF- signaling and increases Msx2
mRNA expression but has no effect on Cbfa1 expression.
Decorin overexpression also caused an upregulation of Msx2
mRNA expression, which was partially prevented by the TGF-
receptor kinase inhibitor. Furthermore, use of XT-I siRNA
blocked Ox-LDL–induced VSMC mineralization, with a con-
comitant decrease of Msx2 mRNA expression, suggesting that
Msx2 is involved in both Ox-LDL– and decorin-induced VSMC
calcification. Taken together, we conclude that oxidative stress–
mediated mineralization of VSMCs in vitro involves the addi-
tion and possible modification of decorin GAG chain, with
subsequent activation of TGF- signaling. Further studies are
needed to verify the importance of this pathway in vascular
calcification using animal models.
Sources of Funding
This work was supported by a Universities UK and University of
Manchester Overseas Research Studentship (to J.Y.) and Arthritis
Research UK grant 18461 (to D.A.). Support from the National
Institute for Health Research Manchester Biomedical Research
614 Arterioscler Thromb Vasc Biol March 2011
 at Cardiff University on February 19, 2014http://atvb.ahajournals.org/Downloaded from 
Centre and the Manchester Academic Health Science Centre
is acknowledged.
Disclosures
None.
References
1. Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong
RY, Di Carli MF. Interrelation of coronary calcification, myocardial
ischemia, and outcomes in patients with intermediate likelihood of
coronary artery disease: a combined positron emission tomography/
computed tomography study. Circulation. 2008;117:1693–1700.
2. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ.
Coronary artery calcium to predict all-cause mortality in elderly men and
women. J Am Coll Cardiol. 2008;52:17–23.
3. Santos RD, Nasir K, Carvalho JA, Raggi P, Blumenthal RS. Coronary
calcification and coronary heart disease death rates in different countries, not
only the influence of classical risk factors. Atherosclerosis. 2009;202:32–33.
4. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates
osteoblastic differentiation of vascular and bone cells. Free Radic Biol
Med. 2001;31:509–519.
5. Damiani E, Sugiyama T, Shimamura K, Greci L, Matsuda Y. Altered
expression of alpha-actin, smooth muscle myosin heavy chain-1 and
calponin in cultured smooth muscle cells by oxidized low density
lipoproteins. FEBS Lett. 1998;425:123–125.
6. Fortuno A, San JG, Moreno MU, Diez J, Zalba G. Oxidative stress and
vascular remodeling. Exp Physiol. 2005;90:457–462.
7. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multi-
faceted disease. Circulation. 2008;117:2938–2948.
8. Takeuchi Y, Kodama Y, Matsumoto T. Bone matrix decorin binds trans-
forming growth factor-beta and enhances its bioactivity. J Biol Chem.
1994;269:32634–32638.
9. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL.
TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular
cells to calcify. J Clin Invest. 1994;93:2106–2113.
10. Fischer JW, Steitz SA, Johnson PY, Burke A, Kolodgie F, Virmani R,
Giachelli C, Wight TN. Decorin promotes aortic smooth muscle cell
calcification and colocalizes to calcified regions in human atherosclerotic
lesions. Arterioscler Thromb Vasc Biol. 2004;24:2391–2396.
11. Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M.
Decorin modulates matrix mineralization in vitro. Biochem Biophys Res
Commun. 2003;305:6–9.
12. Gutierrez J, Osses N, Brandan E. Changes in secreted and cell associated
proteoglycan synthesis during conversion of myoblasts to osteoblasts in
response to bone morphogenetic protein-2: role of decorin in cell
response to BMP-2. J Cell Physiol. 2006;206:58–67.
13. Theocharis AD, Tsolakis I, Tzanakakis GN, Karamanos NK. Chondroitin
sulfate as a key molecule in the development of atherosclerosis and
cancer progression. Adv Pharmacol. 2006;53:281–295.
14. Miyazaki T, Miyauchi S, Tawada A, Anada T, Matsuzaka S, Suzuki O.
Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances
osteoblast differentiation. J Cell Physiol. 2008;217:769–777.
15. Adhikari N, Basi DL, Townsend D, Rusch M, Mariash A, Mullegama S,
Watson A, Larson J, Tan S, Lerman B, Esko JD, Selleck SB, Hall JL.
Heparan sulfate Ndst1 regulates vascular smooth muscle cell prolif-
eration, vessel size and vascular remodeling. J Mol Cell Cardiol. 2010;
49:287–293.
16. Tran-Lundmark K, Tran PK, Paulsson-Berne G, Friden V, Soininen R,
Tryggvason K, Wight TN, Kinsella MG, Boren J, Hedin U. Heparan
sulfate in perlecan promotes mouse atherosclerosis: roles in lipid perme-
ability, lipid retention, and smooth muscle cell proliferation. Circ Res.
2008;103:43–52.
17. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN. Oxidized low
density lipoproteins regulate synthesis of monkey aortic smooth muscle
cell proteoglycans that have enhanced native low density lipoprotein
binding properties. J Biol Chem. 2000;275:4766–4773.
18. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR,
Border WA, Ruoslahti E. Interaction of the small interstitial proteo-
glycans biglycan, decorin and fibromodulin with transforming growth
factor beta. Biochem J. 1994;302(Pt 2):527–534.
19. Gotting C, Kuhn J, Kleesiek K. Human xylosyltransferases in health and
disease. Cell Mol Life Sci. 2007;64:1498–1517.
20. Ruhland C, Schonherr E, Robenek H, Hansen U, Iozzo RV, Bruckner P,
Seidler DG. The glycosaminoglycan chain of decorin plays an important
role in collagen fibril formation at the early stages of fibrillogenesis.
FEBS J. 2007;274:4246–4255.
21. Pan C, Nelson MS, Reyes M, Koodie L, Brazil JJ, Stephenson EJ, Zhao
RC, Peters C, Selleck SB, Stringer SE, Gupta P. Functional abnormalities
of heparan sulfate in mucopolysaccharidosis-I are associated with
defective biologic activity of FGF-2 on human multipotent progenitor
cells. Blood. 2005;106:1956–1964.
22. Deakin JA, Lyon M. A simplified and sensitive fluorescent method for
disaccharide analysis of both heparan sulfate and chondroitin/dermatan
sulfates from biological samples. Glycobiology. 2008;18:483–491.
23. Schonherr E, Broszat M, Brandan E, Bruckner P, Kresse H. Decorin core
protein fragment Leu155-Val260 interacts with TGF-beta but does not
compete for decorin binding to type I collagen. Arch Biochem Biophys.
1998;355:241–248.
24. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y,
Berliner JA, Demer LL. Lipid oxidation products have opposite effects on
calcifying vascular cell and bone cell differentiation. A possible expla-
nation for the paradox of arterial calcification in osteoporotic patients.
Arterioscler Thromb Vasc Biol. 1997;17:680–687.
25. Muller B, Prante C, Gastens M, Kuhn J, Kleesiek K, Gotting C. Increased
levels of xylosyltransferase I correlate with the mineralization of the
extracellular matrix during osteogenic differentiation of mesenchymal
stem cells. Matrix Biol. 2008;27:139–149.
26. Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Mac-
carana M, Westergren-Thorsson G, Malmstrom A. Regulation of the
chondroitin/dermatan fine structure by transforming growth factor-beta1
through effects on polymer-modifying enzymes. Glycobiology. 2005;15:
1277–1285.
27. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of trans-
forming growth factor-beta by the proteoglycan decorin. Nature. 1990;
346:281–284.
28. Abdel-Wahab N, Wicks SJ, Mason RM, Chantry A. Decorin suppresses
transforming growth factor-beta-induced expression of plasminogen ac-
tivator inhibitor-1 in human mesangial cells through a mechanism that
involves Ca2-dependent phosphorylation of Smad2 at serine-240.
Biochem J. 2002;362:643–649.
29. Schaefer L, Raslik I, Grone HJ, Schonherr E, Macakova K, Ugorcakova
J, Budny S, Schaefer RM, Kresse H. Small proteoglycans in human
diabetic nephropathy: discrepancy between glomerular expression and
protein accumulation of decorin, biglycan, lumican, and fibromodulin.
FASEB J. 2001;15:559–561.
30. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming
growth factor-betas with heparin/heparan sulfate is isoform-specific.
J Biol Chem. 1997;272:18000–18006.
31. Malavaki C, Mizumoto S, Karamanos N, Sugahara K. Recent advances in
the structural study of functional chondroitin sulfate and dermatan sulfate
in health and disease. Connect Tissue Res. 2008;49:133–139.
32. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J.
Selective inhibition of activin receptor-like kinase 5 signaling blocks
profibrotic transforming growth factor beta responses in skin fibroblasts.
Arthritis Rheum. 2004;50:4008–4021.
33. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T,
Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas
R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and
ectodermal organ formation. Nat Genet. 2000;24:391–395.
34. Hosokawa R, Urata M, Han J, Zehnaly A, Bringas P Jr, Nonaka K, Chai
Y. TGF-beta mediated Msx2 expression controls occipital somites-
derived caudal region of skull development. Dev Biol. 2007;310:
140–153.
35. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, Cheng SL,
Towler DA. Aortic Msx2-Wnt calcification cascade is regulated by TNF-
alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb
Vasc Biol. 2007;27:2589–2596.
36. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan
CM. Osteo/chondrocytic transcription factors and their target genes
exhibit distinct patterns of expression in human arterial calcification.
Arterioscler Thromb Vasc Biol. 2003;23:489–494.
37. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification:
an early perspective. Am J Physiol Endocrinol Metab. 2004;286:
E686–E696.
Yan et al Decorin Accelerates Vascular Calcification 615
 at Cardiff University on February 19, 2014http://atvb.ahajournals.org/Downloaded from 
 1 
Supplemental Material 
Decorin Accelerates Vascular Calcification 
Methods 
Tissue Collection and Human Vascular Smooth Muscle Cell Culture 
Patients gave informed consent and approval was received from the Local Research Ethics Committee 
(07/H1003/196). The study conforms with the Declaration of Helsinki. Vascular smooth muscle 
cells were isolated using an explant method as described by Endlich et al.1 and used between 
passage 3-6.  Briefly, arteries were placed in saline and kept at 4°C until use (within 1-3 h). The 
muscle layer was dissected free from the surrounding mucosa, cut into small pieces <3 mm3, the 
luminal side of the explants was carefully placed in 6-well plates, in contact with the culture dish (6 to 
10 tissue pieces per well) and cells that had migrated from the explants were collected and maintained 
in regular growth media, Dulbecco's Modification of Eagle's Medium (DMEM, Lonza) supplemented 
with 10% fetal bovine serum (FBS), at 37°C in a humidified incubator containing 5% CO2.  Explanted 
tissue pieces were removed 1 week after the first SMCs appeared. To confirm that the cells isolated 
from human tibial arteries were smooth muscle cells, α-smooth muscle actin (anti-α-SMA, Sigma) 
positive and von Willebrand factor (anti-vWF, DAKO) negative cells were identified by 
immunofluorescence as described previously.2  When the cells reached 80% confluence, growth 
media was replaced by osteogenic media (DMEM with the addition of 5mmol/L beta-
glycerophosphate (Sigma) and 2.6mmol/L calcium). Where indicated, cells were treated with 
30µg/ml Ox-LDL.  
 
LDL Preparation and Oxidation 
The LDL fraction harvested from human plasma was dialyzed extensively against PBS (pH 7.4) at 
4oC with two buffer changes for 24 hours. Protein concentration of LDL was measured using BCATM 
protein assay (Pierce). Oxidation of LDL was performed by incubating LDL with 5 µmol/L CuSO4 at 
37°C for 3 hours, terminated by EDTA (24µmol/L). The extent of oxidation was assessed by the 
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measurement of lipid peroxides using the cholesterol-iodide reagent3 and the absorbance was 
measured at 365nm. The oxidised LDL fraction was dialyzed as above and sterilized by passage 
through a 0.22 µm filter and stored at 4°C for future use. Alizarin red staining showed that Ox-
LDL accelerated calcification of human VSMCs in a dose-dependant manner, an effect not 
detected when using native LDL (Supplementary Figure 1). 30µg/ml ox-LDL was used for all 
future experiments. 
 
Recombinant Adenoviral Infection of Vascular Smooth Muscle Cells 
Cells were seeded in either 25 cm2 cell culture flasks or 6-well plates at 4 x 104 cells/cm2  and grown 
in DMEM supplemented with 10% FBS overnight to reach 80% confluence. A dose-response of 
recombinant adenovirus (RAd) infection was performed using a range of multiplicity of infection 
(MOI) (0 to 150) to assess the most appropriate multiplicity of infection that should be used to 
achieve 90% infection without any cell toxicity.4,5 A multiplicity of infection of 100 was selected for 
this study. 
 
Induction and Determination of Calcification 
Mineralisation of hSMCs was induced using a modification of a method described by Reynolds et 
al.6, Briefly, hSMCs were cultured in regular growth media for several days until they reached 80% 
confluence. At that time, media was switched to osteogenic media, i.e., DMEM (high glucose, 4.5 
g/L) containing 5% FBS, 10 mmol/L sodium pyruvate, 100 U/mL penicillin, 100 µg/mL 
streptomycin, 2.6 mmol/L CaCl2, and 5 mmol/L β-glycerophosphate for up to 3 weeks.  
 
i) Alizarin Red Staining  
Calcium deposition was assessed in cultures of VSMCs using alizarin red staining. VSMCs were 
grown in 6-well plates. Cells were washed with PBS three times and fixed in 4% formaldehyde in 
PBS for 10 minutes at room temperature. The cultures were then washed in PBS and exposed to 2% 
alizarin red (pH4.2) for 5 minutes. Cells were washed with deionized water three times over a 1 hour 
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period and phase contrast images were taken immediately. To quantify the extent of mineralization, 
Alizarin red dye was eluted with 10% formic acid, and the absorbance at 414 nm was determined. 
Data were expressed as optical density units.  
 
ii) Alkaline Phosphatase Assay 
Cells were seeded in 6-well plates at 4 x 105 cells/well.  Proteins were extracted at the required time-
points by freeze-thawing the cells in 0.1% Triton X-100 in PBS. Total cellular proteins were 
measured using BCATM protein assay kit (Pierce Biotechnology). Total protein (15 µg) was assayed 
for alkaline phosphatase (ALP) activity at 405 nm as previously described7, and calculated as nmol/ml 
ρ-nitrophenol converted per microgram of protein per minute. The data are from three experiments 
performed in triplicate and shown as the mean ± S.D. 
  
Western Blot Analysis 
Cell lysates (30 ug) were prepared as previously described2   using lysis buffer (20 mM Tris pH 8.0, 
150 mM NaCl, 1% NP40, 0.1% SDS, 10% glycerol, 1 mM EDTA, 5mM NaF) containing protease 
inhibitor cocktail and quantified using a BCATM protein assay kit (Pierce Biotechnology).  Proteins 
were separated by 10% SDS-polyacrylamide gel electrophoresis (SDS/PAGE) and proteins were 
transferred to nitrocellulose membrane (Bio-Rad), and blocked with 5% BSA, 1% non-fat dried milk 
in Tris-buffered saline with 0.1% Tween 20. Membranes were incubated overnight at 4°C with 
respective antibodies. After incubation with a secondary antibody conjugated to Horseradish 
Peroxidase (1:1000, Dako), detection was performed with SuperSignal West Pico Chemiluminescent 
Substrate (Pierce Biotechnology) and visualised by exposing the membrane to X-ray Hyperfilm 
(Kodak). Membranes were re-probed following submersion in stripping buffer (100 mmol/L β-
mercaptoethanol, 2% SDS, 62.5 mmol/L Tris-HCl pH 6.8 ) for 30 min at 55°C.  
 
Xylosyltransferase  siRNA Transfection  
The Basic Nucleofector Kit for primary smooth muscle cells (Amaxa, Germany) was used for 
transfection of human VSMCs. 1×106 cells were transfected with 30µl of 2.5µmol/L scrambled 
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negative control, XT-I, XT-IІ siRNAs as previously described,8 or 2µg pmaxGFP according to the 
manufacturer’s instructions. The mixture was transferred into a cuvette for electroporation using the 
A033 program (Amaxa, Germany). Cells were transferred to a 6-well plate and grown in pre-warmed 
growth medium for 24 hours, which was then replaced by osteogenic medium containing 30µg/ml 
Ox-LDL. Efficiency of transfection was assessed by microscopy of GFP fluorescent cells following 
transfection with pmaxGFP and showed approximately 30% transfection efficiency (data not shown).  
 
Quantitative Real-Time PCR 
Total RNA was isolated from the cultured human VSMCs using TRIzol Reagent (Invitrogen) 
according to manufacturer’s instructions and treated with DNase I (Roche). 1 µg RNA was reverse 
transcribed with oligo(dT)15 primer. The relative amounts of mRNA were calculated using the 
comparative Ct (threshold cycle) method.9 
 
Quantification of  Active and Total TGF-β1 
TGF-β1 levels in conditioned media were determined using the TGF-β1 EMax Immunoassay kit 
(Promega). 100 µl media were used in the EMax immunoassay, which was performed according to 
the manufacturer’s instructions. The TGF-β1 standard curves generated were linear between 15.6 and 
1,000 pg/ml of the TGF-β1 standard supplied by the manufacturer.  
 
Antibodies Used for Western Blot Analysis 
Membranes were probed using specific primary antibodies: mouse anti-human β-tubulin (1:500, Santa 
Cruz), rabbit anti-human decorin (1:500, Santa Cruz), rabbit anti-human p-smad2 (Ser465/467; 1:500, 
Cell Signalling), and smad2 mouse antibody (L16D3; 1:500, Cell Signalling).  
 
Statistical Analysis 
Data are presented as mean ± SD. Statistical analysis was performed by one-way ANOVA and a value 
of P<0.05 was considered significant. 
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Adenoviral-Mediated Expression of Wild-Type and Mutant Decorin in VSMCs 
To further investigate the role of decorin GAG chain in Ox-LDL-induced mineralisation of 
VSMCs, we used adenoviral-mediated over-expression of a wild-type (Ad/DCN) and a 
mutant GAG-free decorin (Ad/S34A), generated by replacing Ser34 with Ala.10 Cells 
infected with Ad/DCN and Ad/S34A both showed elevated levels of decorin compared to 
control cells (Supplementary Figure 3). 
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Supplementary Figure Legends 
Supplementary Figure I. Effect of Ox-LDL on VSMC mineralization.  Representative 
phase-contrast images of VSMCs grown in the presence of different concentrations of native 
low density lipoprotein (N-LDL) or Ox-LDL (10µg/ml, 20µg/ml, 30µg/ml) for 14 days. 
Mineralization was assessed by alizarin red staining.  Bar=200 µm 
 
Supplementary Figure II. CD/DS disaccharide chromatogram.  HPLC Analysis of 
CS/DS from VSMCs. (A) Raw data showing a representative chromatogram of CS/DS 
disaccharides extracted from whole cell lysates of treated and untreated VSMCs. The inset 
shows expanded view of the peaks from 6 to 16min. (B) 400 pmol CS/DS standards in equal 
quantities which were then used as reference for quantification. Peak 1, ∆UA(2S)-
GalNAc(4S,6S); 2, ∆UA(2S)-GalNAc(4S); 3, ∆UA(2S)-GalNAc(6S); 4, ∆UA-
GalNAc(4S,6S); 5, ∆UA(2S)-GalNAc; 6, ∆UA-GalNAc(4S); 7, ∆UA-GalNAc(6S); 8, ∆UA-
GalNAc. GalNAc is N-acetylated galactose, which is attached to uronic acid (±2S). (C) 
CS/DS disaccharide percentage composition. The peak area of each disaccharide was 
converted to nmol by comparison to CS/DS disaccharide standards of known concentration, 
then converted to a percentage of total CS. The inset shows an expanded view of 
disaccharides 1-6 The % of ∆UA-GalNAc(6S) and ∆UA-GalNAc was significantly different 
in VSMCs treated with ox-LDL (t-test, *p<0.05, **p<0.01). 
 
Supplementary Figure III. Over-expression of decorin using recombinant adenoviruses. Cells 
infected with Ad/lacZ, (lane 1) Ad/DCN or Ad/S34A were grown in osteogenic medium for 4 days. 
VSMC lysates were extracted on day 4. Western blot analysis shows decorin core protein over-
expression in both Ad/DCN and Ad/S34A-infected cells. β-Tubulin was used as a protein loading 
control. 
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Supplementary Figure IV. Effect of SB431542 on Ox-LDL-induced mineralization of VSMCs. 
Cells were grown in the presence or absence of 30ug/ml Ox-LDL for 14 days (n=3). 20µmol/L TGF-β 
receptor kinase inhibitor SB431542 (SB) was used to treat cells in the presence of Ox-LDL. A, Cells 
were stained with alizarin red. Bar=200 µm B, Mineralization was quantified using absorbance at 414 
nm and expressed as optical density units. *P< 0.001.  
 
Supplementary Figure V. Effect of SB431542 on DCN-induced mineralization of VSMCs. Cells 
infected with Ad/lacZ or Ad/DCN were grown in osteogenic medium over a 14-day time course 
(n=3). 10µmol/L TGF-β inhibitor SB431542 (SB) was used to treat cells infected with Ad/DCN. A, 
Cells were stained with alizarin red, Bar=200 µm. B, Mineralization was quantified using absorbance 
at 414 nm and expressed as optical density units. *P< 0.001. 
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